Houston Methodist Hospital
Houston, Texas, 77030, United States
Location status: Recruiting
NCT Number: NCT06664827
The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are:
1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR?
Participants will:
* Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.
Interested in participating?
Request Info18 year–50 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In Houston Methodist rehabilitation clinics these devices are used as standard of care for BFR therapy in many post-operative treatments. General guidelines suggest using ranges between 30% - 80% of limb occlusion pressure (LOP). In our previous research efforts involving BFR the investigators have adhered to these guidelines and experienced no adverse events while observing these ranges to be well tolerated by subjects.
Time frame: From baseline visit to end of treatment at 8 weeks
Ligament thickness will be evaluated by ultrasound imaging measurement.
Time frame: At baseline visit and end of treatment at 8 weeks
Any changes will be evaluated by ultrasound imaging. To calculate the relative measurement, also known as the side-to-side difference (STS), investigators will take measurements from both the dominant and nondominant arms and then calculate difference between the two.
Time frame: From baseline visit to end of treatment at 8 weeks
This value will be measured with a crane scale (a device used to measure force) and will evaluate the participant's maximum force output with different movements. Higher or lower scores don't reflect whether an outcome is better or worse, but rather each participant's scores are only being compared to their own to assess strength change.
Contact information is provided by the study sponsor or research team.
The Methodist Hospital Research Institute
Other
Outcomes of Blood Flow Restriction Training on the Ulnar Collateral Ligament
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06818032
Healthy, Healthy Adult
Burlington, Vermont, United States
View Trial DetailsNCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial DetailsNCT01130545
Cardiac Risk Factors, Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07197047
Healthy, Healthy Participants
Palermo, Italy
View Trial Details